{"id":4420,"date":"2025-11-25T10:49:20","date_gmt":"2025-11-24T23:49:20","guid":{"rendered":"https:\/\/kollinginstitute.org.au\/?post_type=team-members&#038;p=4420"},"modified":"2025-11-25T10:49:20","modified_gmt":"2025-11-24T23:49:20","slug":"dr-eloise-watson-mbchb-fracp","status":"publish","type":"team-members","link":"https:\/\/kollinginstitute.org.au\/staging\/team-members\/dr-eloise-watson-mbchb-fracp\/","title":{"rendered":"Dr Eloise Watson (MBChB, FRACP)"},"content":{"rendered":"\n<ul class=\"wp-block-list\">\n<li>Staff Specialist, Department of Neurology, Wellington Hospital, Capital and Coast District Health Board, New Zealand<\/li>\n<\/ul>\n\n\n\n<p>Dr Watson is currently enrolled in a PhD investigating the prevalence and phenotypic associations of mitochondrial disease genetic variants in healthy control populations. Her clinical expertise and interests are in neurogenetic and movement disorders. She is a consultant neurologist currently establishing clinical services for neurogenetics and mitochondrial diseases in Wellington, New Zealand.<\/p>\n","protected":false},"featured_media":4421,"parent":0,"template":"","meta":{"_acf_changed":false,"_uag_custom_page_level_css":""},"primary-research-area":[57],"class_list":["post-4420","team-members","type-team-members","status-publish","has-post-thumbnail","hentry","primary-research-area-neuroscience-and-pain"],"acf":[],"uagb_featured_image_src":{"full":["https:\/\/kollinginstitute.org.au\/staging\/wp-content\/uploads\/2025\/11\/Eloise_Watson.jpg",946,1000,false],"thumbnail":["https:\/\/kollinginstitute.org.au\/staging\/wp-content\/uploads\/2025\/11\/Eloise_Watson-150x150.jpg",150,150,true],"medium":["https:\/\/kollinginstitute.org.au\/staging\/wp-content\/uploads\/2025\/11\/Eloise_Watson-284x300.jpg",284,300,true],"medium_large":["https:\/\/kollinginstitute.org.au\/staging\/wp-content\/uploads\/2025\/11\/Eloise_Watson-768x812.jpg",768,812,true],"large":["https:\/\/kollinginstitute.org.au\/staging\/wp-content\/uploads\/2025\/11\/Eloise_Watson.jpg",946,1000,false],"1536x1536":["https:\/\/kollinginstitute.org.au\/staging\/wp-content\/uploads\/2025\/11\/Eloise_Watson.jpg",946,1000,false],"2048x2048":["https:\/\/kollinginstitute.org.au\/staging\/wp-content\/uploads\/2025\/11\/Eloise_Watson.jpg",946,1000,false]},"uagb_author_info":{"display_name":"ict-wordpress-support@sydney.edu.au","author_link":"https:\/\/kollinginstitute.org.au\/staging\/author\/"},"uagb_comment_info":0,"uagb_excerpt":"Dr Watson is currently enrolled in a PhD investigating the prevalence and phenotypic associations of mitochondrial disease genetic variants in healthy control populations. Her clinical expertise and interests are in neurogenetic and movement disorders. She is a consultant neurologist currently establishing clinical services for neurogenetics and mitochondrial diseases in Wellington, New Zealand.","_links":{"self":[{"href":"https:\/\/kollinginstitute.org.au\/staging\/wp-json\/wp\/v2\/team-members\/4420","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/kollinginstitute.org.au\/staging\/wp-json\/wp\/v2\/team-members"}],"about":[{"href":"https:\/\/kollinginstitute.org.au\/staging\/wp-json\/wp\/v2\/types\/team-members"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/kollinginstitute.org.au\/staging\/wp-json\/wp\/v2\/media\/4421"}],"wp:attachment":[{"href":"https:\/\/kollinginstitute.org.au\/staging\/wp-json\/wp\/v2\/media?parent=4420"}],"wp:term":[{"taxonomy":"primary-research-area","embeddable":true,"href":"https:\/\/kollinginstitute.org.au\/staging\/wp-json\/wp\/v2\/primary-research-area?post=4420"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}